Nanotechnologies for drug therapy of malignant tumors

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The review brings together experimental data from studies aimed to uncover the opportunities for application of nanotechnology in drug therapy of malignant tumors.

Авторлар туралы

D. Korman

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

L. Ostrovskaya

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: larros@list.ru
Moscow, Russia

N. Bluhterova

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

V. Rikova

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

M. Fomina

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Moscow, Russia

Әдебиет тізімі

  1. H. DeYong and P. J. Borm, Int. J. Nanomedicine, 3, 133 (2008). doi: 10.2147/ijn. S596
  2. S. Cavas, S. Quazi, and T. M. Karpinski, 16, 173 (2021). doi: 10.1186/s11671-021-03628-6
  3. J. Fang, H. Makamura, and H. Maeda, Adv. Drug Delivery Rev., 63, 136 (2011). doi: 10.1016/j.addr.2010.04.009
  4. F. Farjadian, A. Ghasemi, O. Gohari, et al., Nanomedicine (Lond.), 14, 93 (2019). doi: 10.2217/nnm-2018-0120
  5. S. Fu, G. Li, W. Zang, et al., Acta Pharmaceut. Sinica B, 12, 92 (2022). doi: 10.1016/j/apab.2021.08.012
  6. V. V. Veselov, A. E. Nosyrev, L. Jicsnszky, et al., Cancers (Basel), 14, 622 (2022). doi: 10.3390/cancers 14030622
  7. F. Farjadian, S. Ghasemi, M. Akbarian, et al., Front. Chem., 10, 952675 (2022). doi: 10.3389/fchem.2022.952675
  8. M. Y. Yang, R. R. Zhao, Y. F. Fang, et al., Int. J. Pharm., 570, 118663 (2019). DOI: 10.106/jijpharm.2019.118663
  9. H. Mei, S. Cai, D. Huang, et al., Bioact. Mater., 8, 220 (2022). doi: 10.1016/j.bioactmat.2021.06.035
  10. S. Jiang, Y. Fu, X. Zhag, et al., Front. Bioeng. Biothechnol., 9, 799806 (2021). DOI: 10.3389/ fbioe.2021.799806
  11. R. Fan, W. Sun, T. Zhang, et al., Biomed. Pharmacother., 150, 113017 (2022). doi: 10.1016/j.biopha.2022.113017
  12. J. Zhang, S. Li, F. F. An, et al., Nanoscale, 7, 13503 (2015). doi: 10.1039/c5nr03259h
  13. R. Zhang, Z. Zhu, H. Ly, et al., Small, 49, e1903881 (2019), doi: 10.1002/smll.201903881
  14. N. Yu, J. Li, Y. Zhang, et al., RSC Adv. 10, 12999 (2020). doi: 10.1039/dOra01117g
  15. J. Zhang, W. Nie, R. Chen, et al., ACS Nano Lett., 19, 658 (2019). doi: 10.1021/acs.nanolett.8603043
  16. S. Barua and S. Mitragtris, ACS Nano, 7, 9558 (2013). doi: 10.1021/nn403913k
  17. M. Zhou, X. Zhang, Y. Yang, et al., Biomaterials, 34, 8960 (2013). doi: 10.1016/j.biomaterials.2013.07.080
  18. Y. Zhao, F. Chen, Y. Pan, et al., ACS Appl. Mater.Interfaces, 7, 19295 (2015). doi: 10.1021/acsami.5b05347
  19. L. Fan, B. Zhang, A. Xu, et al., Mol. Pharm., 15, 2466 (2018). DOI: 10.1021.acs.molpharmaceut.8b00444
  20. Z. Zhang, L. Xhi, C. Wu, et al., ACS Appl. Mater.Interfaces, 9, 29505 (2017). doi: 10.1021/acsami.760756s
  21. Y. Zheng, Y. Zhao, Y. Jia, et al., Biomaterials, 271, 120716 (2021). doi: 10.1016/j.biomaterials.2021. 120716
  22. J.S. Lan, Y.H. Qin, L. Liu, et al., Int. J. Nanomed., 16, 1775 (2021). doi: 10.2147/IJM.S287806
  23. S. Parveen, F. Arjmand, and S. Tabassum, RSC Adv., 9, 24699 (2019). doi: 10.1039/c9ra04358f
  24. M. Bai, M. Yang, J. Gong, et al., AAPS Pharm. Scitech., 23, 41 (2021). doi: 10.1208/s12249-021-02200-w
  25. E. Merisko-Liversidge, G. Liversidge, and E. R. Cooper, Eur. J. Pharmaceut. Sci., 18, 113 (2003). doi: 10.1016/S0928-0987(o)00257-8
  26. J. U. Junghanns and R. N. Muller, Int. J. Nanomedicine, 3, 295 (2008). doi: 10.2147/ijn. s595
  27. R. N. Muller, S. Gohia, and C. M. Keck, Eur. J. Pharmaceut. Biopharmaceut., 78, 1 (2011). doi: 10.1016/j/ejpb.2011.01.07
  28. V. P. Pardhi, T. Verma, S. A. Flora, et al., Curr. Pharmaceut. Design, 24, 5129 (2018). doi: 10.2174/1381612825666190215121148
  29. Y. Zhang, C. Yang, W. Wang, et al., Sci. Rep., 6, 21225 (2016). doi: 10.1038/srep.21225
  30. J. Gao, Z. Qiao, S. Liu, et al., Eur. J. Pharmaceut. Biopharmaceut., 163, 188 (2021). doi: 10.1016/j.ejpb.2021.04.008
  31. L. Yang, J. Xu, Z. Xie, et al., Asian J. Pharm. Sci., 16, 762 (2021). doi: 10.1016/j.ajps.2021.08.001
  32. Y. Hong, S. Che, B. Hui, et al., Biomed. Pharmacother. 118, 108614 (2019). doi: 10.1016/j/biopha.2019.108614
  33. M. Amin, A. L. Seynhaeve, M. Sharif, et al., Pharmaceutics, 14, 2165 (2022). doi: 10.3390/pharmaceutics14102165
  34. B. Zhao, S. Chen, Y. Hong, et al., Pharmaceutics, 14, 1522 (2022). doi: doi: 10.3390/pharmaceutics14071522
  35. A. G. Attanja, V. Pathak, T. Lammers, et al., Pharmacol. Res. 115, 87 (2017). doi: 10.1016/j.phrs. 2016.11.014
  36. M. Ramachandran, Z. Ma, K. Lin, et al., Nanoscale Adv., 4, 4470 (2022). doi: 10.1039/d2na004885b
  37. B. Li, H. Shao, L. Gao, et al., Drug Deliv., 29, 213 (2022). doi: 10.1080/10717544.2022.2094498
  38. R. Tenchov, J. M. Sasso, X. Weng, et al., ACS Nano, 16, 17802 (2022)
  39. A. C. Anselmo and S. Mitragotri, Bioeng. Translation Med., 1, 10 (2016), doi: 10.1002/btm2.10003
  40. R. Cressey, V. Amrahli, and P. W. So, Biomaterials, 271, 120758 (2021). doi: 10.1016/biomaterials.2021.120758
  41. J. Meng, F. Guo, H. Xu, et al., Sci. Rep., 6, 22390 (2016). doi: 10.1038/srep22390
  42. B. Kneidl, M. Peller, G. Winter, et al., Int. J. Nanomedicine, 9, 4387 (2014]. doi: 10.2147/IJN.S49297
  43. A. A. Manzoor, L. H. Lindner, C. D. Landon, et al., Cancer Res., 72, 5566 (2012). doi: 10.1158/0008-5472.CAN-12-1683
  44. S. H. Pham, Y. Choi, and J. Choi, Pharmaceutics, 12, 630 (2020). doi: 10.3390/pharmaceutics 12070630
  45. L. Xi, C. Li, Y. Wang, et al., J. Pharm. Sci., 109, 2544 (2020). doi: 10.1016/jxphs.2020.05.006
  46. C. D. Landon, J. Y. Park, D. Needham, and M. W. Dewhirst, Open Nanomed. J., 3, 38 (2011). doi: 10.2174/18759335011030100038
  47. S. Limmer, J. Hahn, R. Schmidt, et al., Pharm. Res., 31, 2276 (2014). doi: 10.1007/s11095-014-1322-6
  48. N. Boris and M. W. Dewhist, Adv. Drug Delivery Rew., 178, 113985 (2021). doi: 10.1016/j/addr.2021.113985
  49. P. S. Yarmolenko, Y. Zhao, C. Landon, et al., Int. J. Heperthemia, 26, 485 (2010). DOI: 10.3109/ 12656731003789284
  50. S. Wang, X. G. Mei, S. N. Goldberg, et al., Radiology, 279, 762 (2016). doi: 10.1148/radiol.2015150787
  51. K. Chandana, N. Gupta, and S. Kanna, Asian J. Pharmaceut. Clin. Res., 12, 8, 2019. doi: 10.2215/ajpcr.2019/v12i7.33595
  52. H. Jiang, D. Geng, H. Liu, et al., Drug Delivery, 23, 3665 (2016). doi: 10.1080/10717544.2016.1217954
  53. M. Du and J. Jin, Drug Des. Devel. Ther., 16, 4139 (2022). doi: 10.2147/DDDT.S386100
  54. H. Wei, J. Chen, S. Wang, et al., Int. J. Nanomed., 14, 8603 (2019). doi: 10.2147/IJN.S218988
  55. X. Xiao, F. Terng, C. Shi, et al., Front. Bioeng. Biothechnol., 10, 1024143 (2022). doi: 10.3389/fbiol.2022.1024143
  56. Y. Wang, B. Qin, G. Xia, and S. Choi, AAPS J., 23, 92 (2021). doi: 10.1208/S12248-021-00611-y
  57. M. R. Mollaeva, E. D. Nikolskaya, V. Beganovskaya, et al., Antioxidants, 10, 1985 (2021). doi: 10.3390/antiox10121985
  58. M. B. Sokol, M. V. Chirkina, N. G. Yabbarov, et al., Pharmaceutics, 14, 2333 (2022). doi: 10.3390/pharmaceutic.s14112333
  59. Е. Д. Никольская, О. А. Жунина, Н. Г. Яббаров и др., Биоорг. химия, 43, 274 (2017).
  60. Е. Д. Никольская, О. А. Жунина, Е. А. Василенко и др., Биоорг. химия, 43, 532 (2017).
  61. Е. Д. Никольская, О. А. Жунина, Н. Г. Яббаров и др., Изв. РАН, сер. хим., № 10, 1867 (2017).
  62. M. B. Sokol, E. Nikolskaya, N. G. Yabbarov, et al., J. Biomed. Mater. Res. B. Appl. Biomater., 107, 1150 (2018). doi: 10.1002/jbm.d.34208
  63. M. B. Sokol, N. G. Yabbarov, M. R. Mollaeva, et al., Nanomed. (Lond.), 17, 1217 (2022). doi: 10.2217/nnm-2022-0097
  64. L. Hu, S. Pang, Q. Hu, et al., Biomed. Pharmacother., 75, 26 (2015). doi: 10.1016/j.biopha.2015.08.036
  65. H. Chen, W. He, and Z. Guo, Chem.Commun. (Camb), 50, 9714 (2014). doi: 10.1030/c4co03385
  66. F. L. Wu, J. Zhang, W. Li, et al., Oncotarget, 8, 67189 (2017). doi: 10.18632/oncotarget.18066
  67. J. W. Valle, S. T. Armstrong, C. Newman, et al., Invest. New Drugs, 29, 1029 (2011). doi: 10.1007/S10637-919-9399-1
  68. K. S. Lee, Y. C. Chung, S. A. Im, et al., Breast Cancer Res. Threat., 108, 241 (2008). doi: 10.1007/S10549-007-9591-y
  69. J. Park. B. Sun, and Y. Yeo, J. Control Release, 263, 90 (2017). doi: 10.1016/J.Jconrel.2016.12.040
  70. A. P. Dias, S. da Silva Santos, J. V. da Silva, et al., Int. J. Pharmaceut., 673, 118814 (2020). doi: 10.1016/j/ijpharm.2019.118814
  71. Z. Baber, D. Bartusir-Aebisher, and D. Aerbisher, Molecules, 27, 3237 {2022). doi: 10.3390/molecules27103237
  72. A. A. Chis, C. Dobrea, O. Morgovan, et al., Molecules, 25, 3982 (2020). doi: 10.3390/molecules25173982
  73. Н. Г. Яббаров, Е. Д. Никольская, О. А. Жунина и др., Биоорган. химия, 43, 180 (2017). doi: 10.7868/S013234231702021X
  74. M. W. Amjad, Pharmacy, Pharmacology, 9, 4 (2021). doi: 10.19163/2307-9266-2021-9-1-4-16
  75. P. Kesharwan, R. K. Tekade, and N. K. Jain, Pharm. Res., 32, 1438 (2015). doi: 10.1007/s11095-014-1549-2
  76. A. Kesevan, P. Ilaiyaraja, W. S. Beaula, et al., Eur. J. Pharmaceut., Biopharmaceut., 96, 255 (2015). doi: 10.1016/j.ejpb.2015.08.001
  77. H. Kulhari, D. Pooja, and S. Shrrivastava, Sci. Rep., 6, 23179 (2016). doi: 10.1038/srep23179
  78. M. Zhang, J. Zhu, Y. Zheng, et al., Pharmaceutics, 10, 162 (2018). doi: 10.3390/pharmaceutics10030162
  79. N. K. Jain, M. S. Tare, V. Mishra, et al., Nanomed: Nanothechnology, Biology, Medicine, 11, 207 (2015). doi: 10.1016/j.nano.2014.09.006
  80. K. Sztandera, P. Dzialak, M. Marcinko-Wska, et al., Pharm. Res., 36, 140 (2019). doi: 10.1007/s11095-019-2673-9
  81. N. Yabbarov, E. Nikolskaya, M. Sokol, et al., Int. J. Mol. Sci. 23, 3119 (2022). DOI: 10.33390/ ijms23063119
  82. X. L. Guo, X. X. Kang, Y. Q. Wang, et al., Acta Biomater. 84, 367 (2019). doi: 10.1016/J.actbio.2018.12.007
  83. K. T. Al-Jamal, W. T. Al-Jamal, J. T. Wang, et al., ACS Nano, 7, 1905 (2013). doi: 10.1021/nn305860k

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Russian Academy of Sciences, 2023